AMGN Amgen Corporation: שולי רווח נקי

Amgen Inc - לוגו גרפי של המנפיק AMGN

Amgen Inc. (AMGN) faces logistical risks and challenges in protecting patents on a global scale. The realization margin ratio clearly demonstrates current business efficiency, with 24.10 representing the metric's value today. The company successfully counters biosimilars by implementing innovations, while Robert Bradway's prudent capital management in cardiology and rare pathologies ensures sustainable growth.

Amgen Inc (AMGN) - רווחיות לפי רווח נקי מ-04.07.2022 עד 19.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Amgen Inc. (AMGN)

- שער מניה ותחזית מחירי מומחים:
אנליטיקה מסכמת של החברה:Amgen Corp - AMGN
מוצר המיוצר על ידי Amgen Inc

Amgen Inc. (AMGN) leverages its unique expertise in developing complex protein therapeutics and robust patent protection to maintain high cost resilience. This indicator measures the net profit margin as a percentage of total revenue, reflecting the overall business efficiency after deducting all operating and financial expenses. By analyzing actual sales margins, investors can quickly assess the rate of yield compression during periods of inflationary pressure.